Related content

14-3-3 protein in the CSF of a patient with Hashimoto’s encephalopathy

By Vander T.   Hallevy C.   Alsaed I.   Valdman S.   Ifergane G.   Wirguin I.  

Journal of Neurology, Vol. 251, Iss. 10, 2004-10 ,pp. : 1273-1274

Springer Publishing Company

Access to resources Recommend Favorite

Posterior reversible encephalopathy and alexia without agraphia in a patient with Hashimoto’s encephalopathy

By Yildiz Ozlem   Segmen Hatice   Oztoprak Ibrahim   Bolayir Ertugrul   Topaktas Suat  

Neurological Sciences, Vol. 31, Iss. 4, 2010-08 ,pp. : 523-525

Springer Publishing Company

Access to resources Recommend Favorite

A follow-up ¹⁸F-FDG brain PET study in a case of Hashimoto's encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis

By Pari Elisa   Rinaldi Fabrizio   Premi Enrico   Codella Maria   Rao Renata   Paghera Barbara   Panarotto Maria   Maria Giovanni   Padovani Alessandro  

Journal of Neurology, Vol. 261, Iss. 4, 2014-04 ,pp. : 663-667

Springer Publishing Company

Access to resources Recommend Favorite

Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy

By Thomas Pierre   Valton Luc   Genton Pierre  

Brain, Vol. 129, Iss. 5, 2006-05 ,pp. : 1281-1292

Oxford University Press

Access to resources Recommend Favorite

Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations

By Ferracci F.   Bertiato G.   Moretto G.  

Journal of the Neurological Sciences, Vol. 217, Iss. 2, 2004-02 ,pp. : 165-168

Elsevier

Access to resources Recommend Favorite